Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01838863Phase 2Terminated
A Phase 2 trial of type AB plasma in hemorrhagic shock, sponsored by Denver Health. Started Apr 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01838863.